Imbalance of the protease-antiprotease system against the background of chronic obstructive pulmonary disease in combination with ischemic heart disease

被引:0
|
作者
Kraidashenko, O. O. [1 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Dept Internal Dis 3, Zaporizhia, Ukraine
来源
PATHOLOGIA | 2023年 / 20卷 / 02期
关键词
ischemic heart disease; chronic obstructive pulmonary disease; matrix metalloproteinase 9; tissue inhibitor of metalloproteinases; fibrosis;
D O I
10.14739/2310-1237.2023.2.278133
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of the study: to evaluate the clinical value of the violation of the expression level of MMP-9 and TIMP against the background of chronic obstructive pulmonary disease (COPD) in combination with ischemic heart disease (IHD).Materials and methods. In accordance with the set goal of the study, 26 people with COPD + IHD and 22 practically healthy people were under observation. The average age of patients was 56.68 +/- 1.21 years; 76.92 % were men. In the control group, the average age was 54.37 +/- 1.84 years, 72.73 % were men. The object of the study was ischemic heart disease: angina pectoris. Research methods: external respiration function study, six minute walk test, determination of heart rate variability, the concentration of MMP-9 and TIMP in blood serum was determined by the method of solid-phase enzyme immunoassay.Results. The analysis of the level of expression of proteases and its inhibitor shows that patients with comorbid IHD on the background of COPD demonstrated 8.11 times higher activity of MMP-9 (p < 0.05) compared to a cohort of practically healthy people. Indicators of TIMP activity in patients with IHD on the background of COPD are 1.46 +/- 0.03 mu g/ml, which is statistically significantly lower by 53.21 % (p < 0.05) compared to healthy people (3.12 +/- 0.01 mu g/ml). The presence of reliable correlations between the MMP-9 level and the FEV1 indicator (r =-0.67, p < 0.05), the LF/HF parameter (r =-0.74, p < 0.05) indicates, that when the level of expression of MMP-9 is elevated, there is a more pronounced violation of the function of external respiration and a shift in the sympatho-parasympathetic balance in the direction of sympathetic activation and a decrease in vagal tone in heart rate modulation.The analysis of the meeting frequency with the analysis of conjugation tables showed that in persons in the upper quartile of MMP-9, prognostically negative parameters of the function of external breathing - an isolated decrease in the Tifno index (chi(2) = 5.2 at p = 0.03), as well as the expressiveness of shortness of breath - were recorded more often >= 6 points on the Borg scale when assessing exercise tolerance during the 6-minute walk test (chi(2)= 7.3 at p = 0.02).Conclusions. The obtained data demonstrate that patients with IHD on the background of COPD have a pronounced proteolytic imbalance and disruption of fibrotic processes compared to practically healthy individuals.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [21] RATIONAL CYTOPROTECTIVE THERAPY OF ISCHEMIC HEART DISEASE CONCOMITANT WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Potyazhenko, M.
    Katerenchuk, P.
    Nastroha, T., V
    Nastroha, V. S.
    WORLD OF MEDICINE AND BIOLOGY, 2016, 55 (01): : 72 - +
  • [22] Risk of ischemic heart disease in chronic obstructive pulmonary disease: A nationwide cohort study
    Moon, Ji-Yong
    Kim, Bo-Guen
    Lee, Hyun
    Kang, Min Gu
    Kim, Jong Seung
    RESPIROLOGY, 2023, 28 : 290 - 290
  • [23] Ivabradine in Second Profilacsis of Ischemic Heart Disease in Patients with Combination of Cardiovascular and Chronic Obstructive Pulmonary Diseases
    Garganeeva, Alla
    Bagreeva, Svetlana
    Lishmanov, Yuri
    Minin, Stanislav
    CIRCULATION, 2010, 122 (02) : E224 - E224
  • [24] Quality of life and affective disorders in patients combined with ischemic heart disease with chronic obstructive chronic obstructive pulmonary disease
    Azarenko, V. Ye.
    Kniazieva, O. V.
    MEDICAL PERSPECTIVES-MEDICNI PERSPEKTIVI, 2018, 23 (03): : 260 - 260
  • [25] Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease
    Karoli, N. A.
    Rebrov, A. P.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (03) : 22 - 26
  • [26] BODE INDEX IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN COMBINATION WITH HYPERTENSIVE HEART DISEASE
    Kapustnyk, V. A.
    Kostyuk, I. F.
    Melenevych, A. Ya
    Tverezovskyi, V. M.
    WORLD OF MEDICINE AND BIOLOGY, 2020, 74 (04): : 64 - 67
  • [27] Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease
    Tsvetkova, O. A.
    Veselovskaya, M. V.
    TERAPEVTICHESKII ARKHIV, 2007, 79 (03) : 25 - 29
  • [28] Serine Protease Imbalance in the Small Airways and Development of Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease
    Uemasu, Kiyoshi
    Tanabe, Naoya
    Tanimura, Kazuya
    Hasegawa, Koichi
    Mizutani, Tatsushi
    Hamakawa, Yoko
    Sato, Susumu
    Ogawa, Emiko
    Thomas, Matthew J.
    Ikegami, Machiko
    Muro, Shigeo
    Hirai, Toyohiro
    Sato, Atsuyasu
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2020, 63 (01) : 67 - 78
  • [29] Ubiquitous monitoring system for chronic obstructive pulmonary disease and heart disease patients
    Shin, Il Hyung
    Lee, Jae Ho
    Kim, Hee Chan
    2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-16, 2007, : 3689 - 3692
  • [30] Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management
    Gianluca Campo
    Rita Pavasini
    Michele Malagù
    Susanna Mascetti
    Simone Biscaglia
    Claudio Ceconi
    Alberto Papi
    Marco Contoli
    Cardiovascular Drugs and Therapy, 2015, 29 : 147 - 157